The Correlation Between Serum Glucagon Peptide-1 Levels with Intima Media Thickness of Carotid Artery in Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.58344/jws.v2i3.244Keywords:
type 2 diabetes mellitus, serum glucagon like peptide-1 levels, serum fasting glucagon like-peptide 1 levels, serum 1 hour post prandial glucagon like peptide-1 levels, intima-media thickness, carotid arteryAbstract
Type 2 Diabetes Mellitus is a group of metabolic disorders characterized by clinical hyperglycemia due to defects in insulin secretion, insulin action or both. This study was to determine the correlation between serum fasting Glucagon Like Peptide-1 (fGLP-1) levels and serum 1 hour post prandial Glucagon Like Peptide-1 (1hGLP-1) levels with IMT of carotid artery in patients with Type 2 DM. This study used a correlative analytic with a cross-sectional approach in population of Type 2 DM patients who were treated at the Interna Polyclinic at Dr. Mohammad Hoesin Palembang the IMT of carotid artery was measured with a high-resolution carotid doppler ultrasound B-mode ultrasound machine. The GLP-1 level was measured by the ELISA method. There were 40 subjects with a median age of 52 (40-59) years. A strong negative correlation was found between fGLP-1 serum levels and IMT of carotid artery with r= -0.748; p = 0.000; n=40. This study also found a strong negative correlation between serum levels of 1hGLP-1 and carotid IMT with r = -0.600; p = 0.000; n=40. There is a strong correlation between serum fGLP-1 levels and serum 1hGLP-1 levels with IMT of carotid artery in Type 2 DM patients. Measurement of serum levels of fGLP-1 and 1hGLP-1 may be an important indicator in evaluating cardiovascular risk in Type 2 DM patients. It may also provide guidance in the development of therapies for Type 2 DM patients to reduce the risk of cardiovascular disease.
References
Abhinav, R. P., Williams, J., Livingston, P., Anjana, R. M., & Mohan, V. (2020). Burden of diabetes and oral cancer in India. Journal of Diabetes and Its Complications, 34(11), 107670. https://doi.org/10.1016/j.jdiacomp.2020.107670
Ceriello, A., Novials, A., Ortega, E., Canivell, S., La Sala, L., Pujadas, G., Esposito, K., Giugliano, D., & Genovese, S. (2013). Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care, 36(8), 2346–2350. https://doi.org/10.2337/dc12-2469
Gani, A., & Abdat, M. (2022). Prevalence of Coronary Heart Disease with Risk Factors History of Hypertension and Diabetes Mellitus at the Regional Government Hospital dr. Zainoel Abidin in Aceh. 2nd Aceh International Dental Meeting 2021 (AIDEM 2021), 9–13. http://doi.org/10.2991/ahsr.k.220302.002.
Giménez, M. R., Hoeller, R., Reichlin, T., Zellweger, C., Twerenbold, R., Reiter, M., Moehring, B., Wildi, K., Mosimann, T., & Mueller, M. (2013). Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. International Journal of Cardiology, 168(4), 3896–3901. https://doi.org/10.1016/j.ijcard.2013.06.049.
Ismah, Z., Nst, C. C., & Wahidah, W. (2022). Screening of Diabetes Mellitus and Physical Activity Analysis: A Stepwise WHO Approach. Unnes Journal of Public Health, 11(2), 116–124. https://doi.org/10.15294/ujph.v11i2.43809
Lastya, A., Saraswati, M. R., & Suastika, K. (2014). The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus. BMC Research Notes, 7(1), 1–4.
Le, T. D., Nguyen, N. P. T., Nguyen, S. T., Nguyen, H. T., Tran, H. T. T., Nguyen, T. H. L., Nguyen, C. D., Nguyen, G. T., Nguyen, X. T., & Nguyen, B. D. (2020). The association between femoral artery intima-media thickness and serum glucagon-like peptide-1 levels among newly diagnosed patients with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 3561. doi: 10.2147/DMSO.S264876.
Ozougwu, J. C., Obimba, K. C., Belonwu, C. D., & Unakalamba, C. B. (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol, 4(4), 46–57.
Phi Thi Nguyen, N., Luong Cong, T., Tran, T. T. H., Nhu Do, B., Tien Nguyen, S., Thanh Vu, B., Ho Thi Nguyen, L., Van Ngo, M., Trung Dinh, H., & Duong Huy, H. (2022). Lower Plasma Albumin, Higher White Blood Cell Count and High-Sensitivity C-Reactive Protein are Associated with Femoral Artery Intima-Media Thickness Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus. International Journal of General Medicine, 2715–2725.
Piotrowski, K., Becker, M., Zugwurst, J., Biller-Friedmann, I., Spoettl, G., Greif, M., Leber, A. W., Becker, A., Laubender, R. P., & Lebherz, C. (2013). Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovascular Diabetology, 12(1), 1–5.
Rydosz, A. (2022). Chapter 2 - Diabetes in general (A. B. T.-D. W. N. Rydosz (ed.); pp. 27–92). Academic Press. https://doi.org/https://doi.org/10.1016/B978-0-323-99887-1.00001-7
Shiraishi, D., Fujiwara, Y., Komohara, Y., Mizuta, H., & Takeya, M. (2012). Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation. Biochemical and Biophysical Research Communications, 425(2), 304–308.
Sudarmaji, W. P., Nursalam, N., & Wulandari, S. (2020). Identification of Nursing Problems in Hospitalized Patients with Diabetes Mellitus. Jurnal Ners, 15(2).
Tanaka, M., Matsuo, Y., Yamakage, H., Masuda, S., Terada, Y., Muranaka, K., Wada, H., Hasegawa, K., Shimatsu, A., & Satoh-Asahara, N. (2016). Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects. Metabolism, 65(2), 1–11. https://doi.org/https://doi.org/10.1016/j.metabol.2015.10.009
Xiong, X., Lu, W., Qin, X., Luo, Q., & Zhou, W. (2020). Downregulation of the GLP-1/CREB/adiponectin pathway is partially responsible for diabetes-induced dysregulated vascular tone and VSMC dysfunction. Biomedicine & Pharmacotherapy, 127, 110218. https://doi.org/https://doi.org/10.1016/j.biopha.2020.110218
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of World Science
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
